These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 8118271)

  • 1. [DNA content of ovarian tumors: correlation to established prognostic parameters and clinical course].
    Kristen P; Kaesemann H; Dostert M; Caffier H
    Gynakol Geburtshilfliche Rundsch; 1993; 33 Suppl 1():204-5. PubMed ID: 8118271
    [No Abstract]   [Full Text] [Related]  

  • 2. [Prognostic factors in ovarian carcinoma].
    Sliutz G
    Wien Med Wochenschr; 1996; 146(1-2):14-7. PubMed ID: 8835490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brenner and transitional cell tumours of the ovary. Report of three cases.
    Rantanen V; Grénman S; Kiilholma P; Salmi T; Klemi PJ
    Ann Chir Gynaecol Suppl; 1994; 208():28-32. PubMed ID: 8092766
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ki-67 immunostaining and DNA flow cytometry as prognostic factors in epithelial ovarian cancers.
    Henriksen R; Strang P; Backstrom T; Wilander E; Tribukait B; Oberg K
    Anticancer Res; 1994; 14(2B):603-8. PubMed ID: 8010717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of cellular DNA content on survival in advanced ovarian cancer.
    Friedlander ML; Hedley DW; Taylor IW; Russell P; Coates AS; Tattersall MH
    Cancer Res; 1984 Jan; 44(1):397-400. PubMed ID: 6690054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytofluorometric analysis of the DNA content in ovarian carcinoma and its relationship to patient survival.
    Murray K; Hopwood L; Volk D; Wilson JF
    Cancer; 1989 Jun; 63(12):2456-60. PubMed ID: 2720595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of flow cytometric DNA content analysis in granulosa cell tumor of the ovary.
    Klemi PJ; Joensuu H; Salmi T
    Cancer; 1990 Mar; 65(5):1189-93. PubMed ID: 2302667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of DNA content in epithelial ovarian cancer.
    Gajewski WH; Fuller AF; Pastel-Ley C; Flotte TJ; Bell DA
    Gynecol Oncol; 1994 Apr; 53(1):5-12. PubMed ID: 8175021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cellular DNA content as a new prognostic tool in patients with borderline tumors of the ovary.
    Kaern J; Trope C; Kjorstad KE; Abeler V; Pettersen EO
    Gynecol Oncol; 1990 Sep; 38(3):452-7. PubMed ID: 2172121
    [No Abstract]   [Full Text] [Related]  

  • 10. Multivariate analysis of the prognostic significance of DNA-ploidy and S-phase fraction in ovarian cancer determined by flow cytometry following detection of cytokeratin-labeled tumor cells.
    Kimmig R; Wimberger P; Hillemanns P; Kapsner T; Caspari C; Hepp H
    Gynecol Oncol; 2002 Jan; 84(1):21-31. PubMed ID: 11748971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical value of morphometric and DNA flow cytometric variables as independent predictors of survival in epithelial ovarian carcinoma: a 5-year follow-up study.
    Veerman MM; van der Wurff AA; van de Water M; Kruitwagen RF; Feijen HW; Vos MC
    Int J Gynecol Pathol; 2009 Sep; 28(5):432-41. PubMed ID: 19696612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA ploidy of ovarian dysgerminomas: correlation with clinical outcome.
    Palmquist MB; Webb MJ; Lieber MM; Gaffey TA; Nativ O
    Gynecol Oncol; 1992 Jan; 44(1):13-6. PubMed ID: 1730420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Steroid hormone receptors and flow cytometric DNA ploidy in ovarian carcinoma.
    Grénman SE; Klemi P; Toikkanen S; Kaihola HL; Laippala P; Mäenpää J; Mäkinen J; Grönroos M
    Ann Chir Gynaecol Suppl; 1994; 208():15-9. PubMed ID: 8092763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Flow-cytometric prognostic factors for the survival of patients with ovarian carcinoma: a 5-year follow-up study.
    Volm M; Kleine W; Pfleiderer A
    Gynecol Oncol; 1989 Oct; 35(1):84-9. PubMed ID: 2792909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aspiration cytology of ovarian tumors.
    Granados R
    Curr Opin Obstet Gynecol; 1995 Feb; 7(1):43-8. PubMed ID: 7742515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of long-term survival by flow cytometric analysis of cellular DNA content in patients with advanced ovarian cancer.
    Friedlander ML; Hedley DW; Swanson C; Russell P
    J Clin Oncol; 1988 Feb; 6(2):282-90. PubMed ID: 3276825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of cellular DNA content on survival in ovarian carcinoma.
    Klemi PJ; Joensuu H; Mäenpää J; Kiilholma P
    Obstet Gynecol; 1989 Aug; 74(2):200-4. PubMed ID: 2748056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Flow cytometry as a prognostic indicator in women with borderline epithelial ovarian tumors.
    Harlow BL; Fuhr JE; McDonald TW; Schwartz SM; Beuerlein FJ; Weiss NS
    Gynecol Oncol; 1993 Sep; 50(3):305-9. PubMed ID: 8406192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Flow-cytometric analysis of deoxyribonucleic acid content in advanced ovarian carcinoma: its importance in long-term survival.
    Zanetta G; Keeney GL; Cha SS; Farr GH; Katzmann JA; Wieand HS; Edmonson JH; Podratz KC
    Am J Obstet Gynecol; 1996 Nov; 175(5):1217-25. PubMed ID: 8942491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Flow cytometric analysis of cellular DNA content in epithelial ovarian cancer].
    Arai H; Izumi S; Wada T; Tsutsui F; Yamaoka K; Nozawa S
    Nihon Rinsho; 1992 Oct; 50(10):2439-43. PubMed ID: 1333018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.